1. Home
  2. USNA vs BCYC Comparison

USNA vs BCYC Comparison

Compare USNA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$18.44

Market Cap

342.7M

Sector

Health Care

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.69

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
BCYC
Founded
1992
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.7M
310.7M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
USNA
BCYC
Price
$18.44
$4.69
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
101.8K
319.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$1,060,902,000.00
N/A
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
N/A
P/E Ratio
$46.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$4.24
52 Week High
$38.32
$9.36

Technical Indicators

Market Signals
Indicator
USNA
BCYC
Relative Strength Index (RSI) 48.12 50.31
Support Level $16.77 $4.52
Resistance Level $21.16 $5.22
Average True Range (ATR) 0.84 0.18
MACD 0.04 0.02
Stochastic Oscillator 53.98 65.44

Price Performance

Historical Comparison
USNA
BCYC

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: